As the desire for a shortened design/make/test/learn cycle increases in early drug discovery, the pressure to rapidly deliver drug metabolism pharmacokinetic data continues to rise. From a bioanalytic
YL-IPA08, exerting rapid antidepressant-like and anxiolytic-like effects on behaviors by translocator protein (TSPO) mediation, is a novel compound that has been discovered and developed at our instit
The main pharmacokinetic parameters of CPL207280 compared with those of TAK-875 in rats in the repeat dose 14-day study (n = 6, 3 males and +3 females).